Diselenium-linked dimeric prodrug nanomedicine breaking the intracellular redox balance for triple-negative breast cancer targeted therapy
Author:
Publisher
Elsevier BV
Subject
Pharmaceutical Science,General Medicine,Biotechnology
Reference46 articles.
1. Global cancer statistics: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J. Clin.,2020
2. Core–shell–satellite nanomaces as remotely controlled self-fueling fenton reagents for imaging-guided triple-negative breast cancer-specific therapy;Du;Small,2020
3. Internal wireless electrical stimulation from piezoelectric barium titanate nanoparticles as a new strategy for the treatment of triple-negative breast cancer;Zhan;ACS Appl. Mater. Interfaces,2022
4. Albumin-coated framework nucleic acids as bionic delivery system for triple-negative breast cancer therapy;Zhang;ACS Appl. Mater. Interfaces,2022
5. Reactive oxygen species (ROS)-based nanomedicine;Yang;Chem. Rev.,2019
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cucurbitacin B and Its Derivatives: A Review of Progress in Biological Activities;Molecules;2024-09-04
2. Design of diselenide-containing polyprodrug and its pH/redox co-triggered degradation and slow drug release for tumor-specific chemotherapy;Colloids and Surfaces A: Physicochemical and Engineering Aspects;2024-08
3. Recent Advances in Immunotherapy and Targeted Therapy of Triple Negative Breast Cancer;Current Pharmaceutical Biotechnology;2024-07-31
4. Application of Nanomaterial-Based Sonodynamic Therapy in Tumor Therapy;Pharmaceutics;2024-04-29
5. Diselenide-Bridged Doxorubicin Dimeric Prodrug: Synthesis and Redox-Triggered Drug Release;Molecules;2024-04-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3